Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34014671/

Multiple myeloma is an incurable hematological malignancy that impacts tens of thousands of people every year in the United States. Treatment for eligible patients involves induction, consolidation with stem cell rescue, and maintenance. High-dose therapy with a DNA alkylating agent, melphalan, rema ...